Table 1.

The Socio-demographic and Clinical Characteristics of the Participants

Variable	n (%)/Mean (SD)
Age in years (mean ± SD)	11.45 ± 2.72
Gender
Female n (%)	5(9.80)
Male n (%)	46(90.19)
Mean duration of parental education y, mean (SD)	8.59 ± 4.02
Mean duration of parental age y, mean (SD)	40.94 ± 5.56
Family income status
Minimum wage or lower, n (%)	25(49.01)
Above minimum wage, n (%)	26(50.98)
Chronic disease(s) in the parent(s)
Yes, n (%)	10(19.60)
No, n (%)	41(80.39)
COVID-19 diagnosis in family environment	26(50.98)
Sources of information for COVID-19
Social contacts n (%)	13(25.49)
Internet n (%)	22(43.13)
Television n (%)	47(92.15)
Social media n (%)	20(39.21)
Time spent to get info on COVID-19, h, mean (SD)	1.47 ± 1.51
Time since ASD diagnosis (years), mean (SD)	7.50 ± 3.74
Pre-pandemic schooling status
Yes, n (%)	49(96.07)
No, n (%)	2(3.92)
During-pandemic schooling status
Yes, n (%)	18(35.29)
No, n (%)	33(64.70)
Education
Face-to-face, n (%)	2(3.92)
Online, n (%)	16(31.37)
Pre-pandemic medication use
Yes, n (%)	43(84.31)
No, n (%)	8(15.68)
Medication status
Monotherapy, n (%)  Combination, n (%)	12(23.52) 31(60.78)
Medication continuation during the pandemic
Yes, n (%)	26(50.98)
No, n (%)	17(33.33)

AAP, atypical antipsychotics including aripiprazole, risperidone, olanzapine, and quetiapine; ATX, aomoxetine; MPH, Methylphenidate; MS, Mood stabilizers; SD, Standart deviation; SSRIs, selective serotonin reuptake inhibitors.